UK Industry Welcomes Post-Brexit ‘Windsor Framework’ For Northern Ireland

UK consumer healthcare industry association, PAGB, has welcomed the landmark “Windsor Framework” agreed by the UK and the EU, which proposes that medicines will take a “green lane” from Great Britain to Northern Ireland, while the UK regulator, MHRA, will have UK-wide responsibility for all drug approvals.

Brexit puzzle (AB Visual Arts/Shutterstock.com)

The UK consumer healthcare industry association, PAGB, has welcomed an agreement concerning the supply of medicines to and from Northern Ireland following the UK’s exit from the European Union.

Under the landmark “Windsor Framework” agreed by the UK and the EU, medicines will require no checks or paperwork when exported from Great Britain for sale in Northern Ireland, while the UK regulator, MHRA, will have UK-wide responsibility for all drug approvals

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography